These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 7852499)

  • 41. The antiproliferative effect of opioid receptor agonists on the T47D human breast cancer cell line, is partially mediated through opioid receptors.
    Hatzoglou A; Bakogeorgou E; Castanas E
    Eur J Pharmacol; 1996 Jan; 296(2):199-207. PubMed ID: 8838457
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Kappa1-opioid binding sites are the dominant opioid binding sites in surgical specimens of human pheochromocytomas and in a human pheochromocytoma (KAT45) cell line.
    Kampa M; Margioris AN; Hatzoglou A; Dermitzaki I; Denizot A; Henry JF; Oliver C; Gravanis A; Castanas E
    Eur J Pharmacol; 1999 Jan; 364(2-3):255-62. PubMed ID: 9932731
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Opioid binding to rat and guinea-pig neural membranes in the presence of physiological cations at 37 degrees C.
    Werling LL; Zarr GD; Brown SR; Cox BM
    J Pharmacol Exp Ther; 1985 Jun; 233(3):722-8. PubMed ID: 2989494
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Kappa opioids and TGFbeta1 interact in human endometrial cells.
    Chatzaki E; Margioris AN; Makrigiannakis A; Castanas E; Georgoulias V; Gravanis A
    Mol Hum Reprod; 2000 Jul; 6(7):602-9. PubMed ID: 10871647
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification and characterization of opioid-binding sites present in the Ishikawa human endometrial adenocarcinoma cell line.
    Hatzoglou A; Gravanis A; Margioris AN; Zoumakis E; Castanas E
    J Clin Endocrinol Metab; 1995 Feb; 80(2):418-23. PubMed ID: 7852499
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Ishikawa cells from birth to the present.
    Nishida M
    Hum Cell; 2002 Sep; 15(3):104-17. PubMed ID: 12703541
    [TBL] [Abstract][Full Text] [Related]  

  • 47.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 48.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 49.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 50.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 51.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 52.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 3.